tamibarotene has been researched along with erythrosine in 1 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (erythrosine) | Trials (erythrosine) | Recent Studies (post-2010) (erythrosine) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 15,483 | 108 | 2,574 |
| Protein | Taxonomy | tamibarotene (IC50) | erythrosine (IC50) |
|---|---|---|---|
| Genome polyprotein | Zika virus | 1.7 | |
| large T antigen | Betapolyomavirus macacae | 13.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, KS; Choi, J; de Groot, BL; Gapsys, V; Griesinger, C; Ha, JH; Jee, JG; Kim, BR; Kim, M; Lee, D; Lee, KO; Ryu, KS | 1 |
1 other study(ies) available for tamibarotene and erythrosine
| Article | Year |
|---|---|
Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IXβ Reductase B as a Novel Thrombocytopenia Therapeutic Target.
Topics: Catalytic Domain; Crystallography, X-Ray; Drug Repositioning; Enzyme Inhibitors; Humans; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Oxidoreductases Acting on CH-CH Group Donors; Protein Binding; Small Molecule Libraries; Thermodynamics; United States; United States Food and Drug Administration | 2022 |